Otonomy, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$11.6M
Doctors Paid
395
Transactions
1,758
2021 Total
$123,263
Payment Breakdown by Category
Research$10.7M (92.9%)
Consulting$477,801 (4.1%)
Food & Beverage$13,314 (0.1%)
Royalty/License$12,987 (0.1%)
Travel$10,882 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10.7M | 1,008 | 92.9% |
| Consulting Fee | $477,801 | 117 | 4.1% |
| Grant | $200,671 | 3 | 1.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $105,527 | 61 | 0.9% |
| Food and Beverage | $13,314 | 420 | 0.1% |
| Royalty or License | $12,987 | 17 | 0.1% |
| Travel and Lodging | $10,882 | 25 | 0.1% |
| Education | $1,919 | 106 | 0.0% |
| Space rental or facility fees (teaching hospital only) | $1,500 | 1 | 0.0% |
Payments by Type
Research
$10.7M
1,008 transactions
General
$824,601
750 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Prospective, Randomized, Double Blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease | $6.0M | 11 | 178 |
| A Randomized, Double-blind, Placebo-controlled Phase 1/2 Study of OTO-313 Given as a Single Intratympanic Injection in Subjects With Subjective Tinnitus | $2.3M | 1 | 110 |
| STUDY OF OTO-104 IN SUBJECTS WITH UNILATERAL MENIERE'S DISEASE | $842,639 | 2 | 283 |
| A 6-MONTH EXTENSION STUDY OF OTO-104 IN MENIERE'S DISEASE | $538,440 | 1 | 238 |
| A randomized, Double-Blind, Placebo-Controlled Phase 1/2 study of OTO-413 given as a single intratymoanic injection in subjects with speech-in-noise hearing impairment | $351,801 | 0 | 23 |
| STUDY OF OTO-104 IN SUBJECTS AT RISK FROM CISPLATIN-INDUCED HEARING LOSS | $318,156 | 10 | 62 |
| PHASE 3 STUDY OF OTO-201 IN ACUTE OTITIS EXTERNA | $175,057 | 4 | 70 |
| A randomized, Double-Blind, Placebo-Controlled Phase 1/2 study of OTO-413 given as a single Intratympanic injection in subjects with speech-in-noise hearing impairment | $119,163 | 0 | 11 |
| OPEN-LABEL STUDY OF OTO-201 IN PEDIATRIC SUBJECTS WITH A HISTORY OF OTITIS MEDIA REQUIRING TYMPANOSTOMY TUBES | $71,042 | 1 | 22 |
| A Randomized, Double-blind, Placebo-controlled Phase 1/2 Study of OTO-413 Given as a Single Intratympanic Injection in Subjects With Speech-in-noise Hearing Impairment | $15,492 | 0 | 1 |
| A 6-Month, Multicenter, Phase 3, Open-Label Extension Safety Study of OTO-104 Given At 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease | $10,500 | 0 | 4 |
| A prospective, randomized, double blind, placebo-controlled, multicenter, Phase 3 efficacy and safetystudy of OTO-104 given as a single intratympanic injection in subjects with unilateral Meniere's disease. | $5,450 | 0 | 2 |
| A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease | $4,004 | 0 | 1 |
| An 8-Week, Prospective, Multicenter, Open-Label Study of OTO-201 Given as a Single Administration in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes | $1,138 | 0 | 1 |
| A 6-MONTH EXTENSION STUDY OF OTO-104 IN MENIERES DISEASE | $80.00 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2017 |
|---|---|---|---|---|
| Dr. Robert Hayashi, Md, MD | Pediatrics | Saint Louis, MO | $1,648 | $0 |
| Dr. Xue Liu, Md, MD | Specialist | Miami, FL | $1,500 | $0 |
| Dr. Rachana Shah, M.d, M.D | Pediatric Hematology-Oncology | Cincinnati, OH | $1,351 | $0 |
| Steven Davis, M.d, M.D | Otolaryngology | Torrance, CA | $1,323 | $0 |
| Daniel Choo, M.d, M.D | Pediatric Otolaryngology | Cincinnati, OH | $1,280 | $0 |
| David Freyer, Do, DO | Pediatric Hematology-Oncology | Los Angeles, CA | $1,228 | $0 |
| Debra Don, M.d, M.D | Otolaryngology | San Diego, CA | $1,212 | $0 |
| Dr. Michael Hoa, M.d, M.D | Otolaryngology | Washington, DC | $1,175 | $0 |
| Arun Rangaswami, Md, MD | Pediatric Hematology-Oncology | Palo Alto, CA | $1,166 | $0 |
| Kay Chang, Md, MD | Otolaryngology | Palo Alto, CA | $1,156 | $0 |
| Dr. Matthew Sitton, Md, MD | Pediatric Otolaryngology | Houston, TX | $1,067 | $0 |
| Brian Greffe, Md, MD | Pediatric Hematology-Oncology | Aurora, CO | $1,044 | $0 |
| Jennifer Foster, Md, MD | Pediatric Hematology-Oncology | Houston, TX | $1,020 | $0 |
| Dr. Misal Khan, Md, MD | General Practice | Panama City, FL | $858.00 | $0 |
| Dr. Michael Hoffer, M.d, M.D | Otology & Neurotology | Miami, FL | $625.00 | $0 |
| Paul Lambert, Md, MD | Anesthesiology | Hudson, FL | $432.42 | $0 |
| Dr. Michael Miltich, Md, MD | Otolaryngology | Charlotte, NC | $350.00 | $0 |
| Dr. Kenneth Compton, M.d, M.D | Otolaryngology | Charlotte, NC | $350.00 | $0 |
| Ravindhra Elluru, Md, Phd, MD, PHD | Pediatric Otolaryngology | Indianapolis, IN | $271.62 | $0 |
| Albert Park, Md, MD | Pediatric Otolaryngology | Salt Lake City, UT | $215.45 | $0 |
| Leonard Brown, M.d, M.D | Specialist | Knoxville, TN | $190.19 | $0 |
| Dr. Thomas Nunn, D.o, D.O | Otolaryngology | Tulsa, OK | $174.10 | $0 |
| Dr. Spencer Voth, D.o, D.O | Otolaryngology/Facial Plastic Surgery | Tulsa, OK | $173.61 | $0 |
| Dr. Patrick Buchanan, D.o, D.O | Facial Plastic Surgery | Tulsa, OK | $155.99 | $0 |
| Jaye Downs, D.o, D.O | Student in an Organized Health Care Education/Training Program | Tulsa, OK | $155.99 | $0 |
About Otonomy, Inc.
Otonomy, Inc. has made $11.6M in payments to 395 healthcare providers, recorded across 1,758 transactions in the CMS Open Payments database. In 2021, the company paid $123,263. The top product by payment volume is OTO-313 ($513,049).
Payments were distributed across 27 medical specialties. The top specialty by payment amount is Internal Medicine ($339,126 to 5 doctors).
Payment categories include: Food & Beverage ($13,314), Consulting ($477,801), Research ($10.7M), Travel & Lodging ($10,882), Royalties ($12,987).
Otonomy, Inc. is associated with 4 products in the CMS Open Payments database, including OTO-313, OTO-413, and OTO-104.